• About
  • Subscribe
  • Advertise
  • Contact
Friday, May 16, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Lumibird Medical unveils new Capsulo Nd:YAG laser

by Myles Hume
April 20, 2022
in Business, Company updates & acquisitions, Equipment, Local, News, Products, Technology
Reading Time: 2 mins read
A A
The market will get its first glimpse at the French Society of Ophthalmology Congress next month.

The market will get its first glimpse at the French Society of Ophthalmology Congress next month.

Share on FacebookShare on Twitter

Lumibird Medical has launched its new Capsulo Nd:YAG laser platform, designed for efficient and accurate capsulotomy and iridotomy treatments.

On Tuesday 19 April, the parent company of ophthalmic laser manufacturers Quantel Medical (France and Poland) and Ellex (Australia, Japan and US) unveiled the next generation laser system that it described as easy-to-use and versatile.

In a statement, it said in the literature the incidence of post-operative secondary cataract varies anywhere between 10-50% within three to five years, demonstrating the need for dedicated treatments.

“With the redesign of Quantel Medical’s flagship Nd:YAG Laser, Lumibird Medical delivers Capsulo; the next generation technology, continuing to support this important growing market need,” Lumibird stated.

Mr Matthew Metcalfe, anterior segment laser product manager at Lumibird Medical, said Capsulo is built with exclusive high-quality optics delivering pristine clarity of view into the anterior and posterior segments of the eye.

“Advanced illumination with a variable-height light tower offers dual illumination angles of 16 and 7.5° for anterior and posterior laser applications,” he said.

The Capsulo Nd:YAG laser can be paired with the Quantel Medical Vitra 2 MultiSpot photocoagulating laser, also from Lumibird Medical, combining pan-retinal photocoagulation functionality through a single slit lamp.

Mr Jean-Marc Gendre, CEO of Lumibird Medical added: “Capsulo, when combined with the Vitra 2 photocoagulator, offers an ideal all-in one laser platform, and we are extremely proud to provide this highly versatile solution into the hands of discerning ophthalmologists.”

Delegates attending The French Society of Ophthalmology (SFO) Congress in Paris, 7-9 May 2022, will have the opportunity to see the Capsulo laser on the Lumibird Medical booth #F9. CE Marked and FDA pending, Capsulo laser is now available in the EU.

More reading

Ellex/Quantel Medical to debut dry eye IPL system at RANZCO virtual

A laser treatment approach to floaters

Ellex-Quantel Medical merger takes shape

Tags: CapsuloCapsulo Nd:YAG lasercapsulotomyEllexiridotomyLumibird MedicalNd:YAG laserQuantel Medical

Related Posts

The cost of intravitreal eye injections to manage macular degeneration can discourage many older Australians from continuing treatment. Image: Rose Makin/stock.adobe.com.

Special Report: Intravitreal injections and bulk billing – good for business

by Rob Mitchell
May 16, 2025

Frequent intravitreal injections are vital to help many older Australians keep their eyesight, but the costs can be prohibitive. Insight...

A scene from the movie My Eyes, featuring optometrist Tsu Shan Chambers (right). Image: FanForce Films.

My Eyes film starring Australian optometrist set to open in theatres

by Staff Writer
May 16, 2025

A film highlighting the remarkable journey of a Australian mother determined to save her daughter’s eyesight, and starring a practising...

Dry eye disease affects more than 4 million Australians and one symptom can be chronic eye pain. Image: sruilk/Shutterstock.com.

Aussie link in research on device to combat chronic eye pain

by Staff Writer
May 16, 2025

Research involving Australian patients has returned positive results for a device intended for the treatment of chronic ocular surface pain...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited